Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.

Documenti analoghi

• HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site
  di: Foster, AC, et al.
  Pubblicazione: (1989)
• R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
  di: Hutson, P. H., et al.
  Pubblicazione: (1991)
• The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
  di: Bristow, L. J., et al.
  Pubblicazione: (1993)
• 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.
  di: Kemp, J A, et al.
  Pubblicazione: (1988)
• Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
  di: Löscher, W., et al.
  Pubblicazione: (1994)